The Impact of Different Antibiotic Regimens on the Emergence of Antimicrobial-Resistant Bacteria

被引:81
作者
D'Agata, Erika M. C. [1 ]
Dupont-Rouzeyrol, Myrielle [1 ]
Magal, Pierre [2 ]
Olivier, Damien [3 ]
Ruan, Shigui [4 ]
机构
[1] Univ Havre, Lab Ecotoxicol Milieux Aquatiques, Le Havre, France
[2] Univ Havre, Lab Math Appl, Le Havre, France
[3] Univ Havre, Lab Informat Traitement Informat Syst, Le Havre, France
[4] Univ Miami, Dept Math, Coral Gables, FL 33124 USA
来源
PLOS ONE | 2008年 / 3卷 / 12期
基金
美国国家科学基金会;
关键词
D O I
10.1371/journal.pone.0004036
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Backgroud: The emergence and ongoing spread of antimicrobial-resistant bacteria is a major public health threat. Infections caused by antimicrobial-resistant bacteria are associated with substantially higher rates of morbidity and mortality compared to infections caused by antimicrobial-susceptible bacteria. The emergence and spread of these bacteria is complex and requires incorporating numerous interrelated factors which clinical studies cannot adequately address. Methods/Principal Findings: A model is created which incorporates several key factors contributing to the emergence and spread of resistant bacteria including the effects of the immune system, acquisition of resistance genes and antimicrobial exposure. The model identifies key strategies which would limit the emergence of antimicrobial-resistant bacterial strains. Specifically, the simulations show that early initiation of antimicrobial therapy and combination therapy with two antibiotics prevents the emergence of resistant bacteria, whereas shorter courses of therapy and sequential administration of antibiotics promote the emergence of resistant strains. Conclusions/Significance: The principal findings suggest that (i) shorter lengths of antibiotic therapy and early interruption of antibiotic therapy provide an advantage for the resistant strains, (ii) combination therapy with two antibiotics prevents the emergence of resistance strains in contrast to sequential antibiotic therapy, and (iii) early initiation of antibiotics is among the most important factors preventing the emergence of resistant strains. These findings provide new insights into strategies aimed at optimizing the administration of antimicrobials for the treatment of infections and the prevention of the emergence of antimicrobial resistance.
引用
收藏
页数:9
相关论文
共 50 条
[1]   The dynamics of drug action on the within-host population growth of infectious agents: Melding pharmacokinetics with pathogen population dynamics [J].
Austin, DJ ;
White, NJ ;
Anderson, RM .
JOURNAL OF THEORETICAL BIOLOGY, 1998, 194 (03) :313-339
[2]   Studies of antibiotic resistance within the patient, hospitals and the community using simple mathematical models [J].
Austin, DJ ;
Anderson, RM .
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 1999, 354 (1384) :721-738
[3]   Quantification of plasmid loss in Escherichia coli cells by use of flow cytometry [J].
Bahl, ML ;
Sorensen, SJ ;
Hansen, LH .
FEMS MICROBIOLOGY LETTERS, 2004, 232 (01) :45-49
[4]   Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals [J].
Bergstrom, CT ;
Lo, M ;
Lipsitch, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (36) :13285-13290
[5]   Relative effects of barrier precautions and topical antibiotics on nosocomial bacterial transmission: Results of multi-compartment models [J].
Boldin, B. ;
Bonten, M. J. M. ;
Diekmann, O. .
BULLETIN OF MATHEMATICAL BIOLOGY, 2007, 69 (07) :2227-2248
[6]   Evaluating treatment protocols to prevent antibiotic resistance [J].
Bonhoeffer, S ;
Lipsitch, M ;
Levin, BR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (22) :12106-12111
[7]   Understanding the spread of antibiotic resistant pathogens in hospitals: Mathematical models as tools for control [J].
Bonten, MJM ;
Austin, DJ ;
Lipsitch, M .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (10) :1739-1746
[8]   Development of antimicrobial agents in the era of new and reemerging infectious diseases and increasing antibiotic resistance [J].
Cassell, GH ;
Mekalanos, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (05) :601-605
[9]  
*CONS REX, 2007, PLOS ONE, V2, pE1275, DOI DOI 10.1371/JOURNAL.PONE.0001275
[10]   Combination drugs, an emerging option for antibacterial therapy [J].
Cottarel, Guillaume ;
Wierzbowski, Jamey .
TRENDS IN BIOTECHNOLOGY, 2007, 25 (12) :547-555